Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Frontier Biotechnologies

Market Cap: CN¥5.4b

A commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patient health in China.

Imugene

Market Cap: AU$79.9m

A clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.

Ono Pharmaceutical

Market Cap: JP¥809.4b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Sunshine Lake Pharma

Market Cap: HK$28.3b

Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

Apeloa PharmaceuticalLtd

Market Cap: CN¥18.9b

Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.

Tetratherix

Market Cap: AU$205.4m

Engages in biomaterial and regenerative medicine business in Australia and internationally.

Getein Biotech

Market Cap: CN¥4.1b

Researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally.

Obio Technology (Shanghai)

Market Cap: CN¥4.8b

A biotechnology company, focuses on the development of gene therapy vectors in China.

Duality Biotherapeutics

Market Cap: HK$29.6b

A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

Ferozsons Laboratories

Market Cap: PK₨17.5b

Engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥296.3b

Manufactures and sells pharmaceuticals in Japan.

Makers Laboratories

Market Cap: ₹807.2m

An integrated pharmaceutical company, manufactures and markets formulations in India.

Hvsen Biotechnology

Market Cap: CN¥4.2b

Engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.

Chong Kun Dang Pharmaceutical

Market Cap: ₩1.1t

Engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.

Square Pharmaceuticals

Market Cap: ৳193.6b

Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.

Akero Therapeutics

Market Cap: US$3.7b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Kuros Biosciences

Market Cap: CHF 877.3m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Alto Neuroscience

Market Cap: US$102.9m

Operates as a clinical-stage biopharmaceutical company in the United States.

Vistin Pharma

Market Cap: NOK 1.0b

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.

Immunocore Holdings

Market Cap: US$1.7b

A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.

SenzaGen

Market Cap: SEK 176.4m

Provides non-animal tests for assessing allergenicity.

enGene Holdings

Market Cap: US$332.7m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Century Therapeutics

Market Cap: US$42.1m

A clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.

Pyxis Oncology

Market Cap: US$127.8m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

Belite Bio

Market Cap: US$2.3b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.

PolyPid

Market Cap: US$52.8m

A clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.

Assembly Biosciences

Market Cap: US$397.2m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

Agilent Technologies

Market Cap: US$34.6b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

89bio

Market Cap: US$2.2b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

Insmed

Market Cap: US$28.7b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Replimune Group

Market Cap: US$316.1m

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer.

Sol-Gel Technologies

Market Cap: US$78.0m

Together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally.

MaxCyte

Market Cap: US$163.1m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Vireo Growth

Market Cap: CA$636.4m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Genetic Analysis

Market Cap: €61.1m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Ocugen

Market Cap: US$474.7m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.